Importance and role of independent data monitoring committees (IDMCs) in oncology clinical trials
Guardado en:
Autor principal: | P Schöffski |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/82b9a89344b648f7be2167ceabe25536 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Trial-level factors affecting accrual and completion of oncology clinical trials: A systematic review
por: Cherie L. Hauck, et al.
Publicado: (2021) -
Dose-levels and first signs of efficacy in contemporary oncology phase 1 clinical trials.
por: Charles Ferte, et al.
Publicado: (2011) -
Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials
por: Aurélie Rondon, et al.
Publicado: (2021) -
A Database of Drug Repurposing Clinical Trials in Oncology
por: Pan Pantziarka, et al.
Publicado: (2021) -
Quantitative magnetic resonance imaging biomarkers in oncological clinical trials: Current techniques and standardization challenges
por: Jie Deng, et al.
Publicado: (2017)